Canopy Growth Corporation (CGC) is currently priced at $1.18, showing a decrease of -2.5 cents (-2.08%) from the previous close of $1.2. The trading volume stands at $2.73 million, reflecting a 24.15% increase compared to the average.
CGC's latest quarterly earnings report, released on Thursday, February 5th, had a consensus EPS estimate of -0.03.
The company's net change in cash for the period is $73.26 million, with operating cash flow at -$17.24 million. Cash at the end of the period amounts to $371.32 million.
In the recent period, CGC reported revenue of $74.54 million, resulting in a gross profit of $21.47 million. Operating income stands at -$26.35 million, with a net loss of -$62.63 million.
Key financial ratios include a quick ratio of 4.26, gross profit margin of 22.38%, and a price to book ratio of 0.71.
CGC shows total assets of $1.11 billion, total liabilities of $348 million, and net debt of -$116.20 million.
This report provides a snapshot of Canopy Growth Corporation's current financial status in the market.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.